Work

Macitentan tadalafil fixed dose combination (FDC) in patients with pulmonary arterial hypertension (PAH): A subgroup analysis from A DUE

Year: 2023

Type: conference-abstract

DOI: 10.1183/13993003.congress-2023.pa1196

Authors: Pavel Jansa, Kelly Chin, Ekkehard Grünig, Jakob Hauser, Matthieu Pannaux, Hany Rofael, Fenling Fan

Institutions: Charles University, General University Hospital in Prague, The University of Texas Southwestern Medical Center, German Center for Lung Research, Actelion (Switzerland), Cytel (United States), First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387970571

Cites:

Cited by:

Related to: 10